Bergroth T - Search Results

1

Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.

Bergroth T, Ekici H, Gisslén M, Loes SK, Goh LE, Freedman A, Lampe F, Johnson MA, Sönnerborg A. Bergroth T, et al. J Med Virol. 2009 Jan;81(1):1-8. doi: 10.1002/jmv.21363. J Med Virol. 2009. PMID: 19031460

2

Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir.

Svedhem V, Lindkvist A, Bergroth T, Knut L, Sönnerborg A. Svedhem V, et al. Among authors: bergroth t. J Med Virol. 2005 Aug;76(4):447-51. doi: 10.1002/jmv.20381. J Med Virol. 2005. PMID: 15977242

3

Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and plasma.

Bergroth T, Ekici H, Gisslén M, Hagberg L, Sönnerborg A. Bergroth T, et al. HIV Med. 2009 Feb;10(2):111-5. doi: 10.1111/j.1468-1293.2008.00659.x. HIV Med. 2009. PMID: 19200174 Free article.

4

Discrimination of lamivudine resistant minor HIV-1 variants by selective real-time PCR.

Bergroth T, Sönnerborg A, Yun Z. Bergroth T, et al. J Virol Methods. 2005 Jul;127(1):100-7. doi: 10.1016/j.jviromet.2005.03.007. Epub 2005 Apr 18. J Virol Methods. 2005. PMID: 15893572

5

Presence of M184I/V in minor HIV-1 populations of patients with lamivudine and/or didanosine treatment failure.

Svedhem V, Bergroth T, Lidman K, Sönnerborg A. Svedhem V, et al. Among authors: bergroth t. HIV Med. 2007 Nov;8(8):504-10. doi: 10.1111/j.1468-1293.2007.00502.x. HIV Med. 2007. PMID: 17944683 Free article.

6

Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review.

Cha-Silva AS, Gavaghan MB, Bergroth T, Alexander-Parrish R, Yang J, Draica F, Patel J, Garner DA, Stanford RH, Meier G, McLaughlin JM, Nguyen JL. Cha-Silva AS, et al. Among authors: bergroth t. Am J Ther. 2024 May-Jun 01;31(3):e246-e257. doi: 10.1097/MJT.0000000000001744. Epub 2024 Apr 29. Am J Ther. 2024. PMID: 38691664 Free PMC article.

7

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel.

Weil C, Bergroth T, Eisenberg A, Whiteside YO, Caraco Y, Tene L, Chodick G. Weil C, et al. Among authors: bergroth t. Epidemiologia (Basel). 2023 Aug 10;4(3):309-321. doi: 10.3390/epidemiologia4030031. Epidemiologia (Basel). 2023. PMID: 37606468 Free PMC article.

8

Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID.

Tene L, Bergroth T, Eisenberg A, David SSB, Chodick G. Tene L, et al. Among authors: bergroth t. Int J Infect Dis. 2023 Mar;128:3-10. doi: 10.1016/j.ijid.2022.12.002. Epub 2022 Dec 16. Int J Infect Dis. 2023. PMID: 36529373 Free article.

9

The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018-2019).

Bonanni P, Faivre P, Lopalco PL, Joura EA, Bergroth T, Varga S, Gemayel N, Drury R. Bonanni P, et al. Among authors: bergroth t. Expert Rev Vaccines. 2020 Nov;19(11):1073-1083. doi: 10.1080/14760584.2020.1858057. Epub 2020 Dec 14. Expert Rev Vaccines. 2020. PMID: 33267673 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters